The prognosis of follicular lymphomas (FL) is heterogeneous
and numerous treatments may be proposed. A validated prognostic
index (PI) would help in evaluating and choosing these treatments.
Characteristics at diagnosis were collected from 4167 patients
with FL diagnosed between 1985 and 1992. Univariate and multivariate
analyses were used to propose a PI. This index was then tested
on 919 patients. Five adverse prognostic factors were selected:
age (> 60 years vs 60 years), Ann Arbor stage (III-IV vs
I-II), hemoglobin level (< 120 g/L vs 120 g/L), number of
nodal areas (> 4 vs 4), and serum LDH level (above normal
vs normal or below). Three risk groups were defined: low risk
(0-1 adverse factor, 36% of patients), intermediate risk (2
factors, 37% of patients, hazard ratio [HR] of 2.3), and poor
risk ( 3 adverse factors, 27% of patients, HR = 4.3). This Follicular
Lymphoma International Prognostic Index (FLIPI) appeared more
discriminant than the International Prognostic Index proposed
for aggressive non-Hodgkin lymphomas. Results were very similar
in the confirmation group. The FLIPI may be used for improving
treatment choices, comparing clinical trials, and designing
studies to evaluate new treatments.
相似文献